HAYWARD, Calif.–(BUSINESS WIRE)– #ASTRO23–RefleXion® Medical, a therapeutic oncology company, today announced the company will showcase the RefleXion® X1 with SCINTIX™ biology-guided radiotherapy at the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 1-4, 2023 […]
Dialysis impacts quality of life and can lead to infection and heart damage. Now, some doctors say it’s possible to wean certain patients off dialysis. Click here to view original post
Dr. Peter Antall, former Amwell CMO, joins Lark as Chief Medical Officer and President, Medical Networks as part of clinical expansion MOUNTAIN VIEW, Calif., Sept. 28, 2023 /PRNewswire/ — Lark Health, the leading conversational-AI health […]
GSK’s ViiV Healthcare is eyeing 2026 and 2027 for potential longer-acting versions of its respective HIV injectables for prevention and treatment, executives said on a media call Wednesday. The effort is part of GSK’s plan […]
Advances in the 3D printing of living tissue – a field known as bioprinting – puts within reach the possibility of fabricating whole organs from scratch and implanting them in living beings. A multidisciplinary team […]
For the first time, HumanFirst Institute’s analysis puts numbers to the digital biomarker and clinical outcome assessment (COA) revolution happening in life sciences SAN FRANCISCO, Sept. 28, 2023 /PRNewswire/ — Regulators are increasingly approving AI-powered […]
SAN JOSE, Calif.–(BUSINESS WIRE)–Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that offers satellite buses, transportation, and other in-space infrastructure services, today announced that Chief Executive Officer John Rood is […]
82.4% of patients without prior CAR-T achieving Complete Response (CR) or better SHANGHAI and NANJING, China and SAN JOSE, Calif., Sept. 28, 2023 /PRNewswire/ — IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing […]
IHealth Labs Inc. has moved into a new office at 8950 Cal Center Drive in Sacramento, where it plans to expand a program aimed at helping patients better manage chronic conditions. Click here to view […]
Gritstone bio will get up to $433 million from the US government to run a Phase IIb trial early next year testing its self-amplifying mRNA vaccine candidate with an approved Covid-19 jab, the biotech said […]
Copyright © 2023 Biotech Networks, LLC
